RNA modification m⁶A: A Crucial Factor in Cancer Progression and Treatment
N6-methyladenosine (m⁶A) RNA modification has emerged as a pivotal epigenetic regulator that intricately controls gene expression and profoundly influences cancer ...
Tag: targeted cancer therapeutics
Discovering New DHODH Inhibitors for Cancer Treatment
In the ever-evolving landscape of cancer treatment, researchers are consistently pursuing innovative strategies to combat this multifaceted disease. One of ...
Micropeptide Killswitch Reveals Condensate Microenvironments
In a groundbreaking advancement poised to revolutionize our understanding of oncogenic condensates, researchers have unveiled a novel “killswitch” micropeptide capable ...
HER3-Targeted Antibody-Drug Conjugate Demonstrates Potential Against Treatment-Resistant Solid Tumors
A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310. ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!